Abdul Mannan/LinkedIn

Mar 11, 2026, 15:03

Abdul Mannan: Why Early Recognition of APML-Associated DIC Saves Lives

Abdul Mannan, Consultant Hematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn:

“DIC in APML: Why Early Recognition Saves Lives

DIC in APML kills patients before chemotherapy even starts.

Let me be clear: This is preventable.

I’ve seen too many cases where delayed recognition cost lives.

The bleeding starts fast. ICH, alveolar hemorrhage, GI bleeding.

Major bleeding is the leading cause of early death in APML.

Here’s what saves lives:

Recognize the pattern:

Act immediately:

The pathophysiology matters:

Promyelocytes dump massive amounts of tissue factor.

You get simultaneous clot formation AND breakdown.

Consumption coagulopathy at its worst.

Monitor relentlessly:

Check DIC parameters daily (more often in unstable patients).

A 2019 Blood study showed early death rates dropped from 17% to 5% with protocol-driven aggressive supportive care.

The key? Recognition speed and transfusion support intensity.

Have you managed APML-associated DIC?

What’s your transfusion threshold strategy?”

Abdul Mannan: Why Early Recognition of APML-Associated DIC Saves Lives

Other posts featuring Abdul Mannan on Hemostasis Today.

Abdul Mannan APML APML-associated DIC bleeding disorders DIC Headlines Health Hematology Hemostasis Hemostasis News Hemostasis Today Medicine

'

'

'

'

'

Targeted Thrombolysis Beyond tPA

Hemostasis Today